Price $7.03 |
Market Cap
47.6M
|
Sector Health Care |
Div. Growth
-
|
|
P/E
-
|
P/B
17.39
|
P/S
7.0
|
Dividend %
-
|
|
P/CF
24.7
|
P/FCF
-
|
Op. Cash Flow
-3.7K
|
FCF
-0.5
|
|
Op. Margin
-48.90%
|
Net Margin
-52.20%
|
ROE
-90.40%
|
ROI
-53.80%
|
|
ROA
-36.60%
|
EPS Growth
-87.10%
|
Current Ratio
3.0
|
Debt/Equity
21.10%
|
| Company | Price | P/E | Div. Yield | Market Cap ($Mil) | Rating |
|---|---|---|---|---|---|
| Bausch Health Companies Inc (BHC) | $21.83 | - | - | 8.35B | Strong Buy |
| China Pharma Holdings, Inc. (CPHI) | $0.26 | - | - | 12.3M | Strong Buy |
| Hologic, Inc. (HOLX) | $50.60 | - | - | 13.59B | Strong Buy |
| Biomerica, Inc. (BMRA) | $3.09 | - | - | 33.8M | Strong Buy |
| American Renal Associates Hold (ARA) | $6.96 | - | - | 240.3M | Strong Buy |
Please note that all recommendations are based on our model's results and do not represent our personal opinion. The stock Rating process is purely mechanical.
All analysis relies on publicly available financial information. Learn More
